Delivery Order SPE2DB20D2104-SPE2DB25FMULM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,089.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.26 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count package). This firm fixed-price, competitively awarded delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract represents a continuation of...
- The Defense Logistics Agency awarded a $3,689.52 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Viberzi 75 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $4,307.34. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The order is set for ultimate completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed price contract valued at $1,165.72. This non-set-aside delivery order, issued on July 31, 2025, with completion targeted for August 1, 2025, represents a routine pharmaceutical procurement through the agency's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product used to treat irritable bowel syndrome. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The award was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and represents a child contract under...
- This is a $1,723.18 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the medication Viberzi 100 mg tablets. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely a task order...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,650.57 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Viberzi 100 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed price contract is for the delivery of Viberzi 100 mg Tablets in quantities of 60. The contract has a performance period ending on May 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the company to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMULMDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $2,002.01. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support Defense Health Agency and military healthcare systems worldwide. Viberzi (eluxadoline) is a medication used to treat irritable bowel syndrome with diarrhea. This delivery order exemplifies the company's role in fulfilling specialized pharmaceutical supply requirements for federal healthcare operations through competitively awarded contracts with consistent firm fixed-price terms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/7/25 |